Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 6 | 2020 | 635 | 1.000 |
Why?
|
| Obesity | 10 | 2021 | 1166 | 0.930 |
Why?
|
| Leptin | 4 | 2024 | 83 | 0.850 |
Why?
|
| Bone and Bones | 2 | 2024 | 137 | 0.650 |
Why?
|
| Hyperglycemia | 1 | 2020 | 98 | 0.640 |
Why?
|
| Glucocorticoids | 2 | 2020 | 179 | 0.640 |
Why?
|
| Primary Prevention | 1 | 2017 | 134 | 0.520 |
Why?
|
| Juglans | 3 | 2021 | 11 | 0.490 |
Why?
|
| Health Status | 1 | 2017 | 424 | 0.470 |
Why?
|
| Follistatin | 3 | 2021 | 44 | 0.470 |
Why?
|
| Anti-Obesity Agents | 3 | 2019 | 14 | 0.450 |
Why?
|
| Nephrosis | 1 | 2013 | 3 | 0.440 |
Why?
|
| Hypoparathyroidism | 1 | 2013 | 7 | 0.440 |
Why?
|
| Diabetes Complications | 1 | 2014 | 100 | 0.440 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 657 | 0.430 |
Why?
|
| Risk Assessment | 1 | 2020 | 1920 | 0.420 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2013 | 47 | 0.420 |
Why?
|
| Hospitalization | 1 | 2020 | 1290 | 0.410 |
Why?
|
| Energy Metabolism | 4 | 2024 | 359 | 0.370 |
Why?
|
| Neurosecretory Systems | 2 | 2024 | 24 | 0.350 |
Why?
|
| Weight Loss | 3 | 2019 | 263 | 0.300 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 2 | 2018 | 5 | 0.300 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 2 | 2018 | 7 | 0.300 |
Why?
|
| Blood Glucose | 3 | 2020 | 461 | 0.300 |
Why?
|
| Benzazepines | 2 | 2019 | 21 | 0.290 |
Why?
|
| Activins | 2 | 2018 | 54 | 0.280 |
Why?
|
| Fibronectins | 2 | 2017 | 43 | 0.280 |
Why?
|
| Insulin Resistance | 3 | 2021 | 392 | 0.280 |
Why?
|
| Metabolic Diseases | 2 | 2017 | 54 | 0.270 |
Why?
|
| Coronary Artery Disease | 2 | 2018 | 273 | 0.240 |
Why?
|
| Double-Blind Method | 7 | 2021 | 715 | 0.240 |
Why?
|
| Humans | 24 | 2024 | 59282 | 0.230 |
Why?
|
| Autoantibodies | 2 | 2016 | 172 | 0.210 |
Why?
|
| Food Preferences | 2 | 2021 | 50 | 0.210 |
Why?
|
| Homeostasis | 1 | 2024 | 346 | 0.190 |
Why?
|
| Middle Aged | 13 | 2021 | 16310 | 0.190 |
Why?
|
| Female | 17 | 2021 | 30695 | 0.190 |
Why?
|
| Fasting | 2 | 2019 | 48 | 0.190 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2021 | 6 | 0.190 |
Why?
|
| Myocardial Infarction | 2 | 2018 | 862 | 0.180 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2021 | 13 | 0.180 |
Why?
|
| Thyroid Neoplasms | 1 | 2021 | 71 | 0.180 |
Why?
|
| Risk Factors | 3 | 2020 | 4982 | 0.180 |
Why?
|
| Body Weight | 2 | 2019 | 368 | 0.170 |
Why?
|
| Male | 15 | 2021 | 27727 | 0.170 |
Why?
|
| Gastrointestinal Hormones | 1 | 2019 | 10 | 0.170 |
Why?
|
| Liraglutide | 1 | 2019 | 4 | 0.170 |
Why?
|
| Metabolic Syndrome | 2 | 2017 | 131 | 0.160 |
Why?
|
| Bariatric Surgery | 1 | 2019 | 52 | 0.160 |
Why?
|
| Prefrontal Cortex | 1 | 2019 | 107 | 0.150 |
Why?
|
| Eating | 1 | 2019 | 130 | 0.150 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2018 | 84 | 0.150 |
Why?
|
| Follistatin-Related Proteins | 1 | 2018 | 22 | 0.150 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 2337 | 0.150 |
Why?
|
| Reproduction | 1 | 2018 | 89 | 0.140 |
Why?
|
| Prognosis | 3 | 2021 | 1599 | 0.140 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 461 | 0.140 |
Why?
|
| Appetite Regulation | 1 | 2017 | 8 | 0.140 |
Why?
|
| Nuts | 1 | 2017 | 6 | 0.140 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2017 | 9 | 0.140 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2016 | 158 | 0.140 |
Why?
|
| Functional Food | 1 | 2017 | 36 | 0.140 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2016 | 12 | 0.130 |
Why?
|
| Incidence | 1 | 2020 | 1236 | 0.130 |
Why?
|
| Cost of Illness | 1 | 2017 | 156 | 0.130 |
Why?
|
| Receptor, Insulin | 1 | 2016 | 48 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 151 | 0.130 |
Why?
|
| White Matter | 1 | 2017 | 114 | 0.130 |
Why?
|
| Glycoproteins | 1 | 2017 | 186 | 0.130 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 248 | 0.130 |
Why?
|
| Diet | 1 | 2019 | 497 | 0.120 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 192 | 0.120 |
Why?
|
| Case-Control Studies | 4 | 2021 | 1051 | 0.120 |
Why?
|
| Cross-Over Studies | 3 | 2021 | 153 | 0.120 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2014 | 19 | 0.120 |
Why?
|
| Comorbidity | 1 | 2017 | 1078 | 0.110 |
Why?
|
| WT1 Proteins | 1 | 2013 | 6 | 0.110 |
Why?
|
| GATA3 Transcription Factor | 1 | 2013 | 14 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2016 | 249 | 0.110 |
Why?
|
| Prevalence | 1 | 2017 | 1252 | 0.110 |
Why?
|
| Parathyroid Hormone | 1 | 2013 | 43 | 0.110 |
Why?
|
| Cognitive Dysfunction | 1 | 2017 | 309 | 0.110 |
Why?
|
| Cues | 3 | 2019 | 73 | 0.100 |
Why?
|
| Aged | 5 | 2020 | 13412 | 0.100 |
Why?
|
| Animals | 4 | 2024 | 19601 | 0.100 |
Why?
|
| Felty Syndrome | 1 | 2011 | 2 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 788 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2021 | 6071 | 0.100 |
Why?
|
| Neurons | 1 | 2017 | 863 | 0.090 |
Why?
|
| Brain | 2 | 2017 | 1487 | 0.090 |
Why?
|
| Young Adult | 3 | 2018 | 4266 | 0.090 |
Why?
|
| Postprandial Period | 2 | 2019 | 18 | 0.080 |
Why?
|
| Histones | 1 | 2011 | 457 | 0.070 |
Why?
|
| United States | 1 | 2020 | 7385 | 0.070 |
Why?
|
| Energy Intake | 2 | 2019 | 167 | 0.070 |
Why?
|
| Percutaneous Coronary Intervention | 2 | 2018 | 160 | 0.060 |
Why?
|
| Cognition | 2 | 2019 | 455 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 933 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2017 | 831 | 0.050 |
Why?
|
| Adult | 5 | 2019 | 15663 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 2373 | 0.040 |
Why?
|
| Glicentin | 1 | 2019 | 1 | 0.040 |
Why?
|
| Oxyntomodulin | 1 | 2019 | 2 | 0.040 |
Why?
|
| Peptide YY | 1 | 2019 | 3 | 0.040 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2019 | 19 | 0.040 |
Why?
|
| Protective Factors | 1 | 2019 | 33 | 0.040 |
Why?
|
| Reward | 1 | 2019 | 83 | 0.040 |
Why?
|
| Lipoproteins | 1 | 2019 | 80 | 0.040 |
Why?
|
| Breakfast | 1 | 2017 | 1 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 2059 | 0.040 |
Why?
|
| Satiety Response | 1 | 2017 | 5 | 0.040 |
Why?
|
| Creatine | 1 | 2017 | 24 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2017 | 96 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2017 | 69 | 0.030 |
Why?
|
| Lipids | 1 | 2019 | 300 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 112 | 0.030 |
Why?
|
| Maintenance Chemotherapy | 1 | 2016 | 14 | 0.030 |
Why?
|
| Azathioprine | 1 | 2016 | 27 | 0.030 |
Why?
|
| Boston | 1 | 2017 | 246 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 1025 | 0.030 |
Why?
|
| Risk | 1 | 2017 | 364 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2016 | 27 | 0.030 |
Why?
|
| Inpatients | 1 | 2019 | 291 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2017 | 176 | 0.030 |
Why?
|
| Remission Induction | 1 | 2016 | 137 | 0.030 |
Why?
|
| Rituximab | 1 | 2016 | 80 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2016 | 102 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2016 | 201 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2016 | 341 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 452 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 935 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 365 | 0.030 |
Why?
|
| Emotions | 1 | 2016 | 214 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1189 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2017 | 373 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 1305 | 0.030 |
Why?
|
| Aging | 1 | 2017 | 710 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2372 | 0.020 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2011 | 24 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 515 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 1479 | 0.020 |
Why?
|
| Autoantigens | 1 | 2011 | 129 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 3065 | 0.020 |
Why?
|
| Exercise | 1 | 2017 | 883 | 0.020 |
Why?
|
| Neutrophils | 1 | 2011 | 353 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2011 | 322 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 5128 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 5822 | 0.010 |
Why?
|